• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Search results from the "OB_Rx" table for query on "022047."



Active Ingredient: QUETIAPINE FUMARATE
Dosage Form;Route: TABLET, EXTENDED RELEASE;ORAL
Proprietary Name: SEROQUEL XR
Applicant: ASTRAZENECA
Strength: EQ 50MG BASE
Application Number: N022047
Product Number: 001
Approval Date: May 17, 2007
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View

Active Ingredient: QUETIAPINE FUMARATE
Dosage Form;Route: TABLET, EXTENDED RELEASE;ORAL
Proprietary Name: SEROQUEL XR
Applicant: ASTRAZENECA
Strength: EQ 200MG BASE
Application Number: N022047
Product Number: 002
Approval Date: May 17, 2007
Reference Listed Drug Yes
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View

Active Ingredient: QUETIAPINE FUMARATE
Dosage Form;Route: TABLET, EXTENDED RELEASE;ORAL
Proprietary Name: SEROQUEL XR
Applicant: ASTRAZENECA
Strength: EQ 300MG BASE
Application Number: N022047
Product Number: 003
Approval Date: May 17, 2007
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View

Active Ingredient: QUETIAPINE FUMARATE
Dosage Form;Route: TABLET, EXTENDED RELEASE;ORAL
Proprietary Name: SEROQUEL XR
Applicant: ASTRAZENECA
Strength: EQ 400MG BASE
Application Number: N022047
Product Number: 004
Approval Date: May 17, 2007
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View

Active Ingredient: QUETIAPINE FUMARATE
Dosage Form;Route: TABLET, EXTENDED RELEASE;ORAL
Proprietary Name: SEROQUEL XR
Applicant: ASTRAZENECA
Strength: EQ 150MG BASE
Application Number: N022047
Product Number: 005
Approval Date: Aug 11, 2008
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code:
Patent and Exclusivity Info for this product: View

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through October 2014
Patent and Generic Drug Product Data Last Updated November 25, 2014

-
-